Colfosceril Palmitate belongs to the class of lung surfactants that is used to treat respiratory diseases. It is specifically indicated to treat respiratory distress syndrome (RDS) among premature infants. Colfosceril palmitate aims to improve and reinflate a collapsed area of the lung by replacing the deficient or ineffective endogenous lung surfactant. This reduces the tension and stabilizes the alveoli to prevent it from collapsing.